Create Profile

Creating your profile will enable you to submit photos and stories to get published on News24.

Please provide a username for your profile page:

This username must be unique, cannot be edited and will be used in the URL to your profile page across the entire 24.com network.

Facebook Sign-In

Hi News addict,

Join the News24 Community to be involved in breaking the news.

Log in with Facebook to comment and personalise news, weather and listings.


Johnson & Johnson plans Ebola vaccine testing

22 October 2014, 20:05

New Brunswick - Johnson & Johnson will begin safety testing in early January on a vaccine combination that could protect people from a strain of the deadly Ebola virus.

The health care products maker said Wednesday that the vaccine being developed by its Janssen Pharmaceutical Companies protects against an Ebola strain that is "highly similar" to the virus that has triggered the current outbreak in West Africa. Johnson & Johnson also plans to test whether its vaccine protects against the version causing the outbreak, which has killed more than 4,500 people.

The New Brunswick, New Jersey, company has committed up to $200 million to speed up and expand production of the vaccine program.


Johnson & Johnson is developing the vaccine with the Danish biotech company Bavarian Nordic. It involves a regimen in which two vaccines are delivered two months apart. The combination provided complete protection in animals.

Also read: Spanish woman free of Ebola, final tests shows

There are no proven drugs or vaccines for Ebola, a disease so rare that it's been hard to attract investments in countermeasures. The current outbreak has struck mostly in Liberia, Guinea and Sierra Leone since it emerged 10 months ago.

Several drugmakers are racing to conduct clinical trials of potential vaccines on humans. The World Health Organization is helping coordinate trials of two other experimental vaccines. It hopes to start testing as early as January on more than 20,000 front-line health care workers and others in West Africa.

That testing will go forward only if the vaccines prove safe and trigger an adequate immune-system response in volunteers during clinical trials that are either underway or planned in Europe, Africa and the United States.

One of those vaccines is being developed by the U.S. National Institutes of Health and British drugmaker GlaxoSmithKline from a modified chimpanzee cold virus and an Ebola protein. It is in clinical trials now in Britain and in Mali. The other was developed by the Public Health Agency of Canada and sent to the U.S. Walter Reed Army Institute of Research in Maryland for testing on healthy volunteers.

Shares of Johnson & Johnson climbed $1.34 to $101.70 Wednesday before markets opened and after the company announced the vaccine update.

- AP


Read News24’s Comments Policy

Comment on this story
Comments have been closed for this article.

Read more from our Users

Submitted by
Jayne Zack
I am in ODM to stay, Busia Depu...

Busia Deputy Governor Kizito Wangalwa told Deputy President William on the face that he was in the Orange Democratic Movement to stay. Read more...

Boda Boda operators in Bahati rai...

Motorbike Boda Boda operators from Bahati Sub county on Tuesday took to the streets of Nakuru’s CBD lamenting over what they term is harassment by patrol police officers in the area. Read more...

Submitted by
Gabriel Ngallah
Human Rights activist lives in fe...

The Human rights fraternity in Mombasa is currently living in fear after the home of one of the vocal human rights champion was invaded on Monday night. Read more...

Submitted by
kel wesh
Poisonous milk powder siezed by K...

The Kenya Revenue Authority has seized two containers with illegal milk powder which had been declared as gypsum board at Mombasa port. Read more...

Submitted by
William Korir
Be ready for protests, Raila warn...

Expect protests if meddling with Auditor General continues, Raila Odinga has said. Read more...

Submitted by
Kenya says will return to interna...

Kenya will return to international markets to borrow when it feels the time is right, National Treasury Cabinet Secretary Henry Rotich said on Tuesday. Read more...